Anthropic Acquires Biotech AI Startup Coefficient Bio

AI leader Anthropic has reportedly acquired the stealth biotech startup Coefficient Bio for $400 million in stock. This strategic move signals Anthropic's deepening commitment to the healthcare and life sciences sectors, building upon its previous launch of Claude for Life Sciences. Coefficient Bio, founded by former Genentech computational drug discovery experts, utilizes AI to accelerate drug discovery and biological research. The acquisition, which includes Coefficient Bio's approximately 10-person team, is expected to bolster Anthropic's capabilities in applying AI to critical scientific advancements.